Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Stanford University to study Pathwork’s diagnostic test
The new test uses advanced genomics-based technology to help physicians determine a tumor’s origin in order to optimize cancer-specific treatment. The study will evaluate the test’s ability to
The new test uses advanced genomics-based technology to help physicians determine a tumor’s origin in order to optimize cancer-specific treatment. The study will evaluate the test’s ability to
The company also reported that the Center for Biologics Evaluation and Research (CBER), a division of the FDA, has approved the synopsis to conduct a Phase I clinical
New and existing investors include NIF SMBC Ventures, CSK Venture Capital, Japan Asia Investment and Yasuda Enterprise Development. Proceeds from the financing will be used to advance the
Fougera’s Calcipotriene Topical Solution (scalp solution) is indicated for the topical treatment of chronic, moderately severe psoriasis of the scalp. It is available in a 60ml bottle. David
Peregrine presented preclinical studies demonstrating that PGN635, a fully human antibody discovered as part of their collaboration, exhibits antitumor efficacy by targeting phosphatidylserine (PS). PGN635 was isolated using
Changes in miR-181a levels have been shown to modify the response of immune cells such as T lymphocytes to specific stimuli and its antagonism could lead to a
The proceeds of this financing will be used to repay certain debentures and the existing term debt with National Bank of Canada, as well as for general working
Pursuant to the option agreement, the pre-commercial milestone payments in the amended license agreement will be reduced from $25 million to $7 million payable on or before December
A Phase II human clinical trial with the new combination therapy, consisting of DiaKine’s Lisofylline (LSF) and Kinexum’s Islet neogenesis associated protein (INGAP) peptide, is expected to begin
Clinical trial application acceptance is a key China’s State Food & Drug Administration (SFDA) requirement prior to pursuing a clinical trial and, ultimately, completing commercialization of a pharmaceutical